Seres Therapeutics
MCRB
#10246
Rank
S$4.26 M
Marketcap
$0.49
Share price
1.11%
Change (1 day)
-60.53%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -S$0.18 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.18 Billion34.63%
2023 -S$0.13 Billion-59.97%
2022 -S$0.32 Billion289.57%
2021 -S$81.98 Million-27.3%
2020 -S$0.12 Billion23%
2019 -S$91.69 Million-30.11%
2018 -S$0.14 Billion9.73%
2017 -S$0.12 Billion-0.74%
2016 -S$0.13 Billion70.96%
2015 -S$70.46 Million257.11%
2014 -S$19.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.32 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.34 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.56 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA